Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 676 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22227520G>A |
| Variant | c.1979G>A |
| Variant Start Position | 1979 |
| Location | Exon 20 |
| Amino Acid Change | p.Trp660* |
| ACMG Call | Pathogenic |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Pathogenic | Effect Type | Nonsense |
| Variant Type | SNV |
| PMID | 16636593, 9199930, 29707405, 34141703, 34806794 |
| Article Count | 5 |
| Times Observed | 6-10 |
| Clinical Phenotype | - |
| ACMG Categories | pvs1, pm2, pp1, ppc |
| ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22245637 ref:G alt:A was not found in gnomAD exomes or genomes. chrX:22245638 ref:G alt:A was not found in gnomAD exomes or genomes. |
| Variant in Clinvar | Yes |
| ClinVar Classification | Pathogenic |
| Categories In Literature | pp1, ppc |
| No Contrary Evidence Found | Yes |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | X-22245637-G-A X-22245638-G-A |
| GnomAD Alleles | - |
| DBNSFP Alleles | X-22245637-G-A X-22245638-G-A |
| Other Alleles | X-22245637-GG-AA |
| Note | nan |
| Warnings | - |